FreshRecalls

⚠ Data freshness notice: the most recent refresh of NHTSA was incomplete, so a very recent recall may be missing. Everything shown is accurate as of the last checked time on this page — for anything time-critical, confirm with the official sources linked below.

FDAClass II · Drug · Recalled June 17, 2026

GSMS Incorporated recall — Golden State Medical Supply Inc.

Hazard: Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint.

Class II: may cause temporary or medically reversible health consequences.

View the official FDA enforcement record (openFDA) ↗

Official recall ID
D-0587-2026
Brand
Golden State Medical Supply
Classification
Class II
Units affected
2,961 bottles
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Description

GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured by Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett, Inc., Seymour, IN 47274, Packaged by GSMS Incorporated, Camarillo, CA 93012. NDC 51407-268-90.

Affected products

Companies & origin

Recalling firm location
Camarillo, CA, United States
Firm address
5187 Camino Ruiz, N/A, 93012-8601

Identifying details (verbatim from the notice)

Product codes / lots
Lots: GS065128, GS065844, GS066695, GS067432, GS067993, expires: 01/31/2027.
Distribution
Within the U.S Market.
Firm notified the public via
E-Mail
FDA event ID
99127
Recall initiated
May 29, 2026
FDA classified
June 11, 2026
FDA report date
June 17, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 23, 2026 at 11:04 PM UTC.

Report a data error on this page